The paper coauthored by Nir Eyal argues for the use of a human challenge study that they say could shave months off of a novel coronavirus vaccine timeline.
A team of researchers led by a Rutgers bioethics expert are arguing in a new paper for the use of a human challenge study that they say could shave months off of a novel coronavirus vaccine timeline.
The paper, coauthored by Nir Eyal, director of the Rutgers Center for Population-Level Bioethics, Marc Lipsitch of the Center for Communicable Disease Dynamics at the Harvard T. H. Chan School of Public Health, and Peter G. Smith of the Tropical Epidemiology Group at the London School of Hygiene & Tropical Medicine, was published Tuesday in The Journal of Infectious Diseases.